Intravenous Insulin in Patients With Diabetes After Percutaneous Coronary Intervention (PCI)
Status:
Terminated
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of intravenous insulin/24 hours to
normalize glycemia upon markers of oxidative stress (protein oxidation and total antioxidant
defense) and inflammation (C-reactive protein (CRP) and sCD40L) in diabetic patients
submitted to PCI with stent.
Phase:
N/A
Details
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Collaborators:
Conselho Nacional de Desenvolvimento Científico e Tecnológico FIPE Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil